Live feed
·
INSIDERFiling
Sarepta Therapeutics Inc. logo

Chief Operating Officer Estepan Ian Michael converted options into 8,125 shares and covered exercise/tax liability with 4,176 shares, increasing direct ownership by 2% to 204,699 units (SEC Form 4)